The role of IL-33 is context-dependent: its behavior in steady-state is different than in epithelial injury. IL-33 has a role in signaling within IBD that is still being understood and there is further need to recognize it within the context of potential immunomodulatory therapeutics. This evidence concerns the gene IL33 and inflammatory bowel disease.